Board and management

Education and professional experience: Claus holds an M.Sc. from Copenhagen Business School, Denmark, and an MBA in Strategy and Finance from the UCLA Anderson School of Management. He was CEO of Atos Medical from early 2014 through to the end of 2018. Atos Medical was sold by EQT to PAI Partners during his tenure as CEO in 2016. Claus has held numerous senior leadership positions in Coloplast A/S, a Danish global consumable Medtech company, most recently as President - North America, Japan, and Australia. Before joining Coloplast, Claus spent 10 years within corporate strategy, mergers and acquisitions, and private equity across industries working for McKinsey & Company, Nordic Capital, and Mattel.

Other current engagement: Claus is currently Senior Advisor to KKR & Co. Inc., Chairman of the Board of directors in Clinisupplies Ltd, and Managing Director of Eden Invest LLC

Shareholding in Sedana Medical: 240,000 shares. Independent in relation to the company, its management, and the company´s major shareholders.

Education and professional experience: Hilde Furberg has a M.Sc. in Chemistry from Oslo University, Norway. Hilde is an independent consultant and professional Board member. She has extensive leadership experience from her over 35 years in sales, marketing, strategy, and management within Pharma/Biotech, from both small and large global companies. Hilde has worked operationally in companies such as Genzyme and Baxter, most recently as Senior Vice President EMEA Rare Diseases at Sanofi Genzyme. In addition, Hilde has experience from positions as Board member in BerGenBio, Probi, Pronova, Clavis, Algeta, Tappin, and CombiGene and as Chairman of the Board of directors in Blueprint Genetics.

Other current engagement: Industrial Advisor to Investinor, Board member in PCI Biotech, Bio-Me, Herantis, and Pluvia Biotech.

Shareholding in Sedana Medical: 4,500 shares. Independent in relation to the Company and its management and in relation to major shareholders.

Education and professional experience: Christoffer holds an M.Sc. from Chalmers University of Technology and a master´s degree in economics from the School of Business and Economics at the University of Gothenburg, Sweden. He held positions as Chief Operating Officer and Chief Financial Officer of XVIVO Perfusion AB. He has also led XVIVO’s North American operations and resided in the United States. He has held leading positions in finance and strategic management at Novartis and LG Electronics.

Other current engagement: CEO XVIVO Perfusion AB, Board member Bentley Endovascular Group AB.

Shareholding in Sedana Medical: 20,000 shares. Independent in relation to the company, its management, and the company´s major shareholders.

Education and professional experience: Donna Haire has an M.S. in Biology from Cleveland State University and a B.S. in Biology from the University of Akron, USA. She is an executive with over 30 years of experience in healthcare, pharmaceutical, and medical device industries. Donna has held positions as Executive Vice President at On Target Laboratories, Vice President, Head of Medical Care Global Regulatory Affairs at Bayer, Senior Vice President of Regulatory, Quality, Clinical, and Medical Affairs at AngioDynamics and has held senior level positions at Philips Healthcare and Medtronic. Donna was an Adjunct Professor at the University of Akron School of Law. She served as an AdvaMed Technical and Regulatory Board Committee Member. Donna was designated a U.S. regulatory expert to lead multiple international trade negotiations in regulatory convergence.

Other current engagement: CEO of The Eriah Group, Inc, Board member of FluoGuide A/S.

Shareholding in Sedana Medical: 0 shares. Independent in relation to the company, its management, and the company´s major shareholders.

Education and professional experience: Jens Viebke has a PhD in Polymer Technology from the Royal Institute of Technology of Stockholm and holds an Executive MBA from the Stockholm School of Economics, Sweden. He has held positions as President of Acute Care Therapies and also as the President of the Critical Care and Vascular Systems divisions in the Medical Systems business area at Getinge AB. He has long and broad experience in the healthcare industry and has previously held positions in research and development, as well as strategy and marketing, at large companies in the healthcare industry, including GE Healthcare and Pharmacia & Upjohn.

Other current engagement: Board member Stille AB.

Shareholding in Sedana Medical: 20,000 shares. Independent in relation to the company, its management, and the company´s major shareholders.

Education and professional experience: Johannes holds an MBA, from the University of Texas, and Dipl. Kaufmann, WHU Otto Beisheim School of Management, Germany. From 2013-2021, Johannes was part of the Executive Management team at Orexo AB, most recently as Executive Vice President and Chief Commercial Officer. Prior to joining Orexo, Johannes worked at McKinsey & Company from 2004 to 2013, advising international clients in the pharmaceutical and medical devices industry and the private equity sector.

Shareholding in Sedana Medical: 117,630 shares, 495,000 warrants and 226,762 rights.

Education and professional experience: Stefan holds an M.Sc. in Mechanical Engineering from the Royal Institute of Technology (KTH) Stockholm, Sweden, and TUD Darmstadt, Germany. In addition, he studied business administration and management at Stockholm Business School, Stockholm University. Stefan has around 20 years of experience in leading positions in various industries, principally in manufacturing, logistics, and business development. Former CEO of Svensk Dos AB, CEO of Dipylon Medical AB, and Production Manager at AB Gustavsberg. Founder of Eker Bicycles AB and Eker Production Ltd., Uganda.

Other current engagement: Chairman of the Board Eker Bicycles AB and Eker Production Ltd., Uganda. Owner K-Consulting (sole proprietor).

Shareholding in Sedana Medical: 32,600 shares, 49,200warrants and 70,863 rights.

Education and professional experience: Peter received his doctor´s degree from Karolinska Institutet, Stockholm, in 1997. Before joining Sedana Medical, he worked for twenty years at the Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, and is Board-certified in Anesthesiology (DESA) and Intensive Care (EDIC). He completed his Ph.D. thesis entitled “Isoflurane sedation in Intensive Care Unit patients” at Karolinska Institutet in 2006. He is an Associate professor at Karolinska Institutet, has supervised several Ph.D. students in ICU sedation, pain monitoring, and long-term outcomes research, and remains active in ICU-related research. Previous positions: Senior Consultant, Head of Neurocritical Care, Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital.

Other current engagement: Associate professor, Department of Physiology and Pharmacology, Karolinska Institutet.

Shareholding in Sedana Medical: 229,468 shares, 69,073 warrants and 70,863 rights.

Education and professional experience: Johan holds an M.Sc. in Economics and Business Administration from the Stockholm School of Economics (Handelshögskolan). Over the period 2013-2021, Johan worked at the investment bank Pareto Securities, of which 2015-2021 as partner and Head of Equity Research in Stockholm. Prior to joining Pareto Securities, Johan worked as a financial analyst at Goldman Sachs in London and New York, 2009 - 2013.

Shareholding in Sedana Medical: 115,073 shares, 69,073 warrants and 70,863 rights.

Education and professional experience: Karolina has a law degree from Stockholm University. Karolina has been active as a legal counsel in the pharmaceutical industry for more than 15 years. Prior to joining Sedana Medical, Karolina worked at Oncopeptides as General Counsel. Previously, Karolina has worked at Gilead Sciences, Biovitrum, and Swedish Orphan Biovitrum (Sobi) in various positions in Legal Affairs.

Shareholding in Sedana Medical: 0 shares. 70,863 rights.

Education and professional experience: Jessica holds an M.Sc. in Analytical Chemistry at Umeå University, Sweden. She is a former employee at Unimedic AB (2006-2020) as Head of Quality and Product Development, and before that at AstraZeneca (1998-2006).

Shareholding in Sedana Medical: 0 shares, 18,260 warrants and 70,863 rights. Related parties 5,692 shares.

Education and professional experience: Uwe holds a Healthcare Degree from University Münster from 2003 with a State Exam in Intensive care and Anesthesia from 2008 with six years of clinical experiences in different medical departments. In addition he holds a Bachelor Professional of Pharmaceutical Consultancy (CCI) from October 2021. He started his career in Sedana Medical as an Area Sales Manager in October 2009 and was promoted to Country Manager Germany in 2016, as of July 1 he holds the position of General Manager Germany.

Shareholding in Sedana Medical: 0 shares or warrants. 70,863 rights

Education and professional experience: Education and professional experience: Sinéad holds an MSc in Marketing Management from the University of Central Lancashire and brings over 15 years of commercial and strategic marketing experience in the Medtech sector, with a focus on Anaesthesia and Respiratory Care. Since 2019 , she has held senior roles at Aerogen, most lately as Global Strategic Marketing Manager and Interim Marketing Director. Her prior roles at Venner Medical, Teleflex and LMA included responsibility for global product management and new market development.

Shareholding in Sedana Medical: 0 shares or warrants.